Bibliografías temáticas / Oral Candidiasis

Índice

  1. Artículos de revistas
  2. Tesis
  3. Libros
  4. Capítulos de libros
  5. Actas de conferencias
  6. Informes

Literatura académica sobre el tema "Oral Candidiasis"

Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 31 de enero de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Oral Candidiasis".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Oral Candidiasis"

1

Marroquín-Remón, Rosmin y Patricia Chang. "Candidiasis oral". Revista médica (Colegio de Médicos y Cirujanos de Guatemala) 160, n.º 3 (8 de diciembre de 2021): 333–36. http://dx.doi.org/10.36109/rmg.v160i3.370.

Texto completo
Resumen
A continuación, se presenta el caso de un paciente masculino de 20 años de edad con diagnóstico de candidiasis oral. Antecedentes de enfermedad renal crónica KDOQI V, trasplante renal con disfunción de injerto de 2 años, actualmente en hemodiálisis, linfoma de células grandes tipo B
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Dellinger, Tracy M. y H. Mark Livingston. "Oral Candidiasis". Annals of Pharmacotherapy 37, n.º 10 (octubre de 2003): 1529. http://dx.doi.org/10.1345/aph.1d125.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Ray, Thomas L. "Oral Candidiasis". Dermatologic Clinics 5, n.º 4 (octubre de 1987): 651–62. http://dx.doi.org/10.1016/s0733-8635(18)30708-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Peterson, Douglas E. "Oral Candidiasis". Clinics in Geriatric Medicine 8, n.º 3 (agosto de 1992): 513–28. http://dx.doi.org/10.1016/s0749-0690(18)30461-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Millsop, Jillian W. y Nasim Fazel. "Oral candidiasis". Clinics in Dermatology 34, n.º 4 (julio de 2016): 487–94. http://dx.doi.org/10.1016/j.clindermatol.2016.02.022.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Akpan, A. "Oral candidiasis". Postgraduate Medical Journal 78, n.º 922 (1 de agosto de 2002): 455–59. http://dx.doi.org/10.1136/pmj.78.922.455.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Lynch, Denis P. "Oral candidiasis". Oral Surgery, Oral Medicine, Oral Pathology 78, n.º 2 (agosto de 1994): 189–93. http://dx.doi.org/10.1016/0030-4220(94)90146-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Ravić-Nikolić, Ana. "Oral candidiasis". Galenika Medical Journal 1, n.º 4 (2022): 48–52. http://dx.doi.org/10.5937/galmed2204050r.

Texto completo
Resumen
Oral candidiasis is an opportunistic fungal infection of the oral cavity, most often caused by Candida albicans. It is common in infants and the elderly. It is mostly asymptomatic in healthy adults. Predisposing factors that contribute to the occurrence of oral candidiasis can be local and systemic, and the clinical course can be acute and chronic. Application of local therapy is sufficient in the majority of cases, but in resistant cases systemic anti-fungal therapy must be commenced, especially in persons with a compromised immune response. Prevention of oral candidiasis is very important - it implies education of the general population about their habits, such as alcohol consumption and smoking, regularly brushing teeth with toothpaste and using antiseptics for rinsing the oral cavity, maintaining the hygiene of dental prostheses, and regular visits to the dentist. In cases where the changes persist despite all the treatment measures taken, it is necessary to rule out malignancies of the oral cavity and conditions of severe acquired immunodeficiency.
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Limbhore, Mayur Vilas, Shandilya Ramanojam, Pallavi Rathi, Vikrant Sane y Adil Mevawala. "ORAL CANDIDIASIS: AN OVERVIEW AND CASE REPORT". Era's Journal of Medical Research 6, n.º 2 (diciembre de 2019): 160–66. http://dx.doi.org/10.24041/ejmr2019.147.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Kim, Chorok y Jihyun Song. "Association between Candidiasis and Early Childhood Caries : Analysis Using Healthcare Big Data". JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY 47, n.º 4 (30 de noviembre de 2020): 359–67. http://dx.doi.org/10.5933/jkapd.2020.47.4.359.

Texto completo
Resumen
The aim of this study was to identify the association between candidiasis and early childhood caries and to investigate whether the experience of candidiasis or oral candidiasis before age 1 can be considered as a risk factor for early childhood caries.<br/>The database used in this study was provided by Health Insurance Review and Assessment Service. Medical records of children born from January 2010 to December 2012 were obtained, and those without dental records were excluded. Subjects were divided into several groups based on the experience of candidiasis or oral candidiasis before age 6: candidiasis group and non-candidiasis group; oral candidiasis group and non-oral candidiasis group. Another categorization was done according to the experience of candidiasis or oral candidiasis before age 1. The incidence rate of early childhood caries in each group were compared.<br/>The prevalence of dental caries in children who have been diagnosed with candidiasis or oral candidiasis before age 6 was significantly different from those who have not experienced candidiasis. Similarly, children who have suffered from candidiasis or oral candidiasis before age 1 had significantly different incidence of caries from the children without candidiasis experience.
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Oral Candidiasis"

1

Samaranayake, Yuthika Hemamala. "Pathogenic attributes of candida krusei with particular reference to the oral cavity". Thesis, Hong Kong : University of Hong Kong, 1995. http://sunzi.lib.hku.hk/hkuto/record.jsp?B14024494.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Naglik, Julian Richard. "Candida albicans secreted aspartyl proteinases and human mucosal candidiasis". Thesis, King's College London (University of London), 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271292.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Queiroz, Vanessa Cristina Pin Piazentin. "Avaliação do potencial antifúngico de própolis de Apis mellifera contra leveduras do gênero Candida". [s.n.], 2010. http://repositorio.unicamp.br/jspui/handle/REPOSIP/288528.

Texto completo
Resumen
Orientadores: Pedro Luiz Rosalen, Marta Cristina Teixeira Duarte
Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba
Made available in DSpace on 2018-08-16T16:26:49Z (GMT). No. of bitstreams: 1 Queiroz_VanessaCristinaPinPiazentin_M.pdf: 4355114 bytes, checksum: 2e7009da410cba032963dee4cd9aa7ac (MD5) Previous issue date: 2010
Resumo: A candidíase oral é uma infecção fúngica que tem sido relatada como problema de saúde pública e em decorrência de um crescente índice de cepas resistentes de Candida spp., tem-se aumentado o interesse em produtos naturais como fonte de novos compostos bioativos. Neste sentido, a própolis brasileira apresenta importantes propriedades farmacológicas como antimicrobiana e poderia ser estudada quanto à sua atividade antifúngica. Assim, o objetivo deste trabalho foi avaliar a atividade anti-Candida de três tipos de própolis brasileiras contra formas planctônicas e em biofilme de Candida spp. de maiores incidências em patologias da cavidade oral. Foram utilizados três tipos de própolis selecionadas por suas propriedades antimicrobianas em estudos prévios, os quais estão classificadas na literatura como: tipo 3 (interior do estado do Paraná), tipo 6 (região de mata atlântica do estado da Bahia) e tipo 13 (região de mangue da cidade de Maceió, estado de Alagoas). Para cada tipo de própolis foram obtidos o extrato etanólico (EEP) e suas respectivas frações com diferentes gradientes de polaridade (hexano, diclorometano e acetato de etila). Aos EEP e respectivas frações foram aplicadas as seguintes metodologias para avaliação da atividade antifúngica contra Candida spp. de forma a conduzir um estudo bioguiado: 1- Determinação da Concentração Inibitória Mínima (CIM) e Concentração Fungicida Mínima (CFM) dos EEP dos tipos 3, 6 e 13 e frações hexânica (fr-hex), diclorometânica (fr-dicloro) e acetato de etila (fr-acet) contra as formas planctônicas das leveduras, obtidas de um banco internacional de cepas Centraalbureau voor Schimmelcultures (CBS): Candida albicans (CBS 562), Candida dubliniensis (CBS 7987), Candida glabrata (CBS 07), Candida krusei (CBS 573), Candida parapsilosis (CBS 604), Candida tropicalis (CBS 94), pelo método da microdiluição. 2- Determinação da CIM das própolis 3 e 13 (EEP e respectivas frações diclorometânicas) sobre biofilmes em pré-adesão. 3- Verificação de possíveis alterações ou danos na estrutura celular das leveduras quando submetidas às própolis 3 e 13 (EEP e respectivas frações diclorometânicas) pela Microscopia Eletrônica de Varredura (MEV) em biofilmes em pré-adesão e formados. De maneira geral, as própolis dos tipos 3 e 13 demonstraram forte atividade anti-Candida contra as leveduras analisadas (valores mínimos e máximos de CIM 4,0 e 31,3 µg/mL para EEP da própolis 3 e 1,0 e 7,8 µg/mL para EEP da própolis 13) em relação a do tipo 6 que demonstrou baixa atividade. O EEP tipo 13 e respectiva fr-dicloro se destacaram, por apresentarem efeito fungicida contra todas as cepas analisadas com valores mínimos e máximos de CFM 125 e 500 µg/mL para a fr-dicloro tipo 13. As própolis 3 e 13 (EEP e respectivas fr-dicloro) apresentaram atividade anti-biofilme em pré-adesão com valores máximos de 250 µg/mL para EEP tipo 3 (C. parapsilosis) e 250 µg/mL para fr-dicloro tipo 3 (C. parapsilosis) e CIM 125 µg/mL para EEP tipo 13 (C. tropicalis) e 31,3 µg/mL para fr-dicloro tipo 13 (C. parapsilosis). As imagens de MEV mostram a interferência dos EEP tipos 3 e 13 e respectivas fr-dicloro sobre biofilmes em pré-adesão, entretanto as própolis não foram capazes de desagregar completamente os biofilmes formados de Candida spp se comparadas ao grupo controle (Nistatina). Conclui-se que os três tipos de própolis estudadas apresentaram atividade anti-Candida tanto em organização planctônica quanto em biofilme, entretanto, a fração diclorometânica da própolis do tipo 13 é a fração ativa, que contém importantes compostos efetivos contra Candida spp. e pode ser fonte de novos princípios bioativos para prevenção ou tratamento da candidíase oral, a qual deve ser objeto de estudos futuros
Abstract: Oral candidiasis is a fungal infection that has been reported as a public health problem and due to increased rate of resistant strains of Candida spp. has increased the interest in natural products as sources for new bioactive compounds. Brazilian propolis have important biological properties such as antimicrobial and anticariogenic activity, thus antifungal activity could also be evaluated. The aim of this study was to evaluate the anti-Candida activity of three Brazilian propolis against planktonic and biofilm forms of Candida spp. of higher incidences in oral cavity diseases.Three types of propolis were selected for antimicrobial properties in previous studies, which are classified in the literature as type 3 (within the state of Parana state), type 6 (Atlantic Rainforest of Bahia state) and type 13 (mangrove region, Maceió city, Alagoas state). For each type of propolis were obtained the ethanolic extract (EEP) and respective fractions with different gradient polarity (hexane, dichloromethane and ethyl acetate). The following methodologies were applied on EEP and correspondent fractions to evaluate antifungal activity against Candida spp. by a bioguided study: 1 - Determination of Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentrations (MFC) of EEP types 3, 6 and 13 and hexane (hex-fr), dichloromethane (dichlo-fr) and ethyl acetate (ethyl-fr) against planktonic forms of yeasts from an international bank Centraalbureau voor Schimmelcultures (CBS): Candida albicans (CBS 562), Candida dubliniensis (CBS 7987), Candida glabrata (CBS 07), Candida krusei (CBS 573), Candida parapsilosis (CBS 604), Candida tropicalis (CBS 94) using the microdilution method. 2 - Determination of MIC of propolis 3 and 13 (EEP and dichloromethane fractions) on preformed biofilm. 3 - Verification of possible changes or damages of the yeast cell structure when subjected to 3 and 13 propolis (EEP and dichloromethane fractions) by Scanning Electron Microscopy (SEM) in preformed and mature biofilms. In most cases, propolis types 3 and 13 demonstrated strong anti-Candida activity against the yeasts tested (minimum and maximum MIC values 4.0 and 31.3 µg/mL for EEP type 3 and 1.0 and 7.8 µg/mL for EEP type 13 compared to the low effect of propolis type 6. EEP type 13 and respective dichlo-fr had the best fungicidal effect against all strains (minimum and maximum MFC values 125 and 500 µg/mL). EEP type 3 and 13 and their dichlo-fr presented anti-biofilm activity 250 µg/mL for EEP type 3 (C. parapsilosis), 250 µg/mL for dichlo-fr type 3 (C. parapsilosis) and (maximum MIC 125 µg/mL for EEP type 13 (C. tropicalis), 31.3 µg/mL for dichlo-fr type 13 (C. parapsilosis). SEM images show the influence of propolis samples on preformed biofilms, however these samples were not capable of completely disrupting the mature biofilms, if compared to control (Nistatin). Thus, we concluded that the three types of propolis studied presented anti-Candida activity both in organization and in planktonic biofilm, however, the dichloromethane fraction of propolis type 13 is the active fraction, which contains important compounds effective against Candida spp. and could be a source of new bioactive principles for prevention or alternative treatment of oral candidiasis, which should be the object of future studies
Mestrado
Farmacologia, Anestesiologia e Terapeutica
Mestre em Odontologia
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Jurevic, Richard Joseph. "Genetic variations in human beta defensin genes and their relationship to oral health and disease /". Thesis, Connect to this title online; UW restricted, 2004. http://hdl.handle.net/1773/6386.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Albougy, Hany Ahed. "A systematic review of the management of oral candidiasis associated with HIV/AIDS". Thesis, Stellenbosch : Stellenbosch University, 2002. http://hdl.handle.net/10019.1/52713.

Texto completo
Resumen
On t.p.: Degree MSc Dental Science (Community Dentistry)
Thesis (MSc)--Stellenbosch University, 2002.
ENGLISH ABSTRACT: The purpose of this review was to investigate the management of oral candidiasis in HIV/AIDS patients and to evaluate the different guidelines that are available for its management. To achieve this aim, three objectives were identified: (i) to identify and report on the different interventions used to manage oral candidiasis, in patients with HIV/AIDS, (ii) to determine the efficacy of these interventions, and (iii) to provide guidelines for management. A thorough systematic search of the literature was carried out and all relevant papers were graded into three levels of evidence (A, B, and C) and scored for quality according to set criteria. A number of topical and systemic antifungal medications are used to treat oral candidiasis in HIV-positive patients. These include the poleyne antibiotics, nystatin and amphotericin B. Milder episodes of oral candidiasis respond to topical therapy with nystatin, clotrimazole troches or oral ketoconazole. Fluconazole has been extensively evaluated as a treatment for candidiasis. With HIV-infection, a cure rate of 82% has been achieved with a daily oral dose of 50 mg. Fluconazole was found to be a better choice of treatment for relapsing oropharyngeal candidiasis, resulting in either better cure rates or better prevention of relapse. Intravenous amphotericin B has been found to be effective therapy in azole refractory candidiasis where it was shown to be safe and well tolerated. Topical therapies were found to be effective treatment for uncomplicated oropharyngeal candidiasis, however patients relapsed more quickly than those treated with oral systemic antifungal therapy. Overall, nystatin appears less effective than clotrimazole and the azoles in the treatment of oropharyngeal candidiasis. With regard to the resolution of clinical symptoms, clotrimazole was found to be just as effective as the azoles, except when patient compliance was poor. Fluconazole-treated patients were more likely to remain disease-free during the fluconazole follow-up period than with those treated with other interventions. Relatively few studies were qualified to address the provision of guidelines for the management of oral candidiasis in primary health care settings. Most of the studies found were of moderate and low quality level of evidence. These studies included the assessment of different guidelines for identification, treatment and dental needs. They stressed that patients with HN need dentists who will act as primary health care providers, together with other providers to ensure adequate overall care. Given the level of interest and importance of candidiasis associated with treatment of HN -positive patients, it is surprising to find that little high quality research has been undertaken. As such, it is hoped that this review would provide researchers, oral health care workers and other health care providers with an overview of the management of oral candidiasis associated with HN/AIDS.
AFRIKAANSE OPSOMMING: Die doelstelling van die oorsig was om ondersoek in te stel na die hantering van orale kandidiase in HIV/AIDS pasiënte asook om die verskillende beskikbare riglyne vir die behandeling daarvan te evalueer. Ter verwesenliking van hierdie doelstelling is drie doelwitte geïdentifiseer: (i) om die intervensies wat gebruik word in die hantering van orale kandidiase behandeling te identifiseer, (ii) om die effektiwiteit van hierdie intervensies te identifiseer en (iii) om op grond hiervan riglyne vir die hantering voor te stel. 'n Sistematiese literatuursoektog is uitgevoer en alle relevante artikels is in drie groepe geklassifiseer (A, B en C) op grond van die data kwaliteit. 'n Verskeidenheid topikale en sistemiese antifungale middels word gebruik om orale kandidiase in HIV-positiewe pasiënte te behandel. 'n Sukseskoers van 82% is met die gebruik van 'n daaglikse dosis van 50 mg medikament gerapporteer. Fluconazole was die beter keuse van middel vir die behandeling van terugkerende orofaringeale kandidiase. Topikale behandeling was effektief in die behandeling van ongekompliseerde orofaringeale kandidiase, hoewel die kans op terugkeer van die toestand groter was as met die sistemiese middels. Pasiënte wat met flukonasool behandel is, het 'n groter kans gehad om siektevry te bly vergeleke met pasiënte op die ander intervensies. Meeste van die studies was van middelmatige tot lae kwaliteit en gevolglik was dit moeilik om behandelingsriglyne te stel. Wat egter wel duidelik is, is dat HIV pasiënte primêre mondsorg benodig wat saam met ander versorging omvattende sorg sal verseker.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Schmidt-Westhausen, Andrea Maria. "Experimentelle Untersuchungen zur Pathogenese und Therapie der oralen Candidiasis bei Immundefizienz". Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2001. http://dx.doi.org/10.18452/13748.

Texto completo
Resumen
Ziel der vorliegenden Arbeit war anhand eines Tiermodells zu untersuchen, 1. ob eine Dosis-Wirkungsbeziehung zwischen der Keimmenge und der Entstehung einer oralen C. albicans Infektion besteht, 2. welche zelluläre Immunantwort auf definierte inokulierte Keimmengen stattfindet, 3. ob sich die Adhärenz von C. albicans an murine Epithelzellen durch Spaltprodukte von Muzin (Glykopeptide) verhindern läßt. Material und Methode: Immunkompetente Inzuchtmäuse (Balb/c) (n=27) und Mäuse mit kombiniertem B- und T-Zelldefekt (SCID) (n=30) wurden mit Keimmengen von10^4 bis 10^8 C. albicans-Zellen/10 mikrol des Stammes DSM 3454 oral inokuliert. Darüber hinaus wurden Balb/c Mäuse (n=8) mit 10^8 C. albicans-Zellen in Kombination mit Glykopeptiden und SCID Mäuse (n=8) mit 10^5 C. albicans-Zellen mit Glykopeptiden inokuliert. Eine Zungenhälfte wurde histologisch mittels Periodic-Acid-Schiff (PAS) Reaktion auf Invasion von Hyphen untersucht. Die andere Hälfte wurde mittels Immunperoxidase-Technik auf die Verteilung immunkompetenter Zellen (CD4, CD13, ICAM-1, E-Selectin, CD74, CD80, CD86, CD103) im Epithel und subepithelialen Bindegewebe untersucht. Ergebnisse: Eine Woche post inoculationem fanden sich weder bei Balb/c noch bei SCID Mäusen klinische Zeichen einer oralen Candidiasis. Die histologischen Ergebnisse mittels PAS-Methode zeigten jedoch, daß eine Inokulationsmenge von 10^8 C. albicans-Zellen bei Balb/c Mäusen und 10^8 Keime bei SCID Mäusen zu einer Infektion der Zungenmukosa führte. Das Ausmaß der immunologischen Reaktion war abhängig von der Inokulationsdosis sowie vom Immunstatus der Tiere. Die Ergebnisse der Inokulation von 10^8 C. albicans-Zellen zusammen mit Glykopeptiden zeigten bei 2/8 Balb/c Mäusen eine Hypheninvasion in das Zungenepithel. Bei 0/8 SCID Mäusen wurde nach Inokulation von 10^4 C. albicans-Zellen zusammen mit Glykopeptiden eine Hypheninvasion in das Zungenepithel beobachtet. Die immunhistochemischen Ergebnisse zeigten, daß die Reaktionen des Wirtes auf die Gabe der Keim-Glykopeptidlösung denen ohne Inokulation entsprachen. Schlußfolgerung: Obwohl bei den eingesetzten C. albicans-Mengen keine klinisch manifeste orale Candidiasis vorhanden war, fanden sich in beiden Tierstämmen inapparente Infektionen des Zungenepithel (Hypheninvasion), die immunologische Reaktionen der Zungenmukosa auslösten. Da nach Inokulation von C. albicans-Zellen zusammen mit Glykopeptiden weniger häufig Infektionen nachgewiesen werden konnten als bei Inokulation derselben Keimmenge ohne Glykopeptide und Nebenwirkungen dieser antiadhäsiven Wirkstoffe bisher nicht nachgewiesen wurden, wäre der unterstützende Einsatz von Muzinen oder deren Spaltprodukten bei Patienten mit erhöhtem Candidiasisrisiko zu erwägen.
This study applied an animal model to address the following questions: 1. Does a dose/effect relationship exist between C. albicans load and the emergence of an oral C. albicans infection, 2. which cellular immune response takes place following inoculation with defined pathogen loads, 3. is it possible to inhibit C. albicans adhesion to murine epithelium cells through the local application of mucine metabolites (glycopeptides). Material and methods: Immunocompetent inbred mice (Balb/c) (n=27) and mice with combined B- and T-cell defects (SCID) (n=30) were orally inoculated with pathogen loads between 10^4 and 10^8 C. albicans cells/10 microl (strain DSM 3454). Moreover, Balb/c mice (n=8) were inoculated with 10^8 C. albicans cells in combination with glycopeptides; SCID mice (n=8) were inoculated with 10^5 cells, also in combination with glycopeptides. One half of the tongue tissue was histochemically examined with the Periodic Acid Schiff (PAS) Method for displaying the invasion of hyphae. The other half of the tissue was examined by immune peroxidase technique for analysing the distribution of immunocompetent cells (CD4, CD13, ICAM-1, E-Selectin, CD74, CD80, CD86, CD103) in the epithelial layers and subepithelial connective tissue. Results: One week following the inoculation, neither group's tissue showed clinical signs of oral candidiasis. Following histochemical preparation (PAS-Reaction) the tongue mucosa showed signs of infection (hyphae) with the inoculation dose of 10^8 C. albicans cells in the case of Balb/c mice and a load of 10^5 pathogens in the case of SCID mice. The extent of the immunologic reaction depended both on the inoculation dose given to the animals and on their immune status. The results of an inoculation of 10^8 C. albicans cells in combination with glycopeptides showed hyphae invasion of the tongue epithelium in 2/8 Balb/c mice. Following an inoculation of 10^5 pathogens in combination with glycopeptides hyphae invasion could be demonstrated in 0/8 SCID mice. The results of immunohistochemical studies showed that the host's reaction to combined glycopeptide-pathogen-inoculation correspond to the reaction without inoculation. Conclusion: Despite the lack of clinical signs of oral candidiasis in neither group's tissue, non-apparent infections of the tongue epithelium were evident leading to immunologic reactions of the tongue mucosa. Inoculation of C. albicans cells in combination with glycopeptides resulted in decreased infection rate compared to a corresponding inoculation dose without glycopeptides. As no side effects have been documented for the oral application of these antiadhesive agents, their use as complimentary therapy for patients at an increased risk for oral candidiasis should be considered.
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Paporn, Kaveewatcharanont. "The effect of fixed orthodontic appliances on the oral carriage of Candida species and coliforms in adolescents". Thesis, Hong Kong : University of Hong Kong, 1993. http://sunzi.lib.hku.hk/hkuto/record.jsp?B13436004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Torrealba, Durán Claudia Cecilia. "Susceptibilidad in vitro de levaduras del género cándida aisladas de un grupo de pacientes con candidiasis oral frente a azoles y polienos". Tesis, Universidad de Chile, 2007. http://repositorio.uchile.cl/handle/2250/139076.

Texto completo
Resumen
Trabajo de Investigación Requisito para optar al Título de Cirujano Dentista
Autor no autoriza el acceso a texto completo de su documento
Las infecciones fúngicas son comúnmente provocadas por hongos del género Candida.(6) C.albicans es la especie más frecuente(17)y en menor proporción otras como:glabrata, tropicalis y krusei. (8) Candida dubliniensis es una nueva especie identificada recientemente de cavidad oral en pacientes VIH.Estudios recientes muestran un notable incremento en el diagnóstico de Candidiasis orales(8),debido a diferentes factores facilitadores.(5,9) Así,el objetivo de este trabajo fue determinar la susceptibilidad “in vitro” de levaduras del género Candida, aisladas de pacientes chilenos con Candidiasis oral, a Nistatina, Fluconazol, Itraconazol y Voriconazol.Nuestra hipótesis plantea que la susceptibilidad de levaduras del género Candida, (Candida albicans y Candida no albicans,) aisladas de pacientes con Candidiasis oral dependen tanto de la especie de Candida como del antifúngico empleado (Azoles y Polienos). El estudio incluyó 74 cepas tales como; 41 Candida albicans,16 Candida dubliniensis,6 Candida glabrata,4 Candida famata,3 Candida krusei, 2 Candida lusitanie y 1 Candida.parapsilosis agrupadas en Candida albicans y Candida no albicans (n=33) que fueron evaluados por el método de microdilución en caldo según el documento M27-A (NCCLS)(13) Candida albicans (n=41)fueron sensibles a Fluconazol y 27 (n=33) Candida no albicans.Las especies no sensibles a Fluconazol fueron albicans, glabrata y krusei.38 Candida albicans (n=41) y 26 cepas de Candida no albicans (n=33) fueron sensibles a Itraconazol.Las especies no sensibles a Itraconazol fueron albicans, glabrata, lusitanie y dubliniensis . Las 74 especies, tanto Candida albicans como Candida no albicans, fueron sensibles a Voriconazol y Nistatina. Con el análisis estadísticos se concluyó que la susceptibilidad de levaduras del género Candida, agrupadas en Candida albicans y Candida no albicans, aisladas de pacientes chilenos con Candidiasis oral, depende tanto de la especie de Candida como del antifúngico empleado (Azoles y Polienos). (p=0,014).
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Al-Dwairi, Ziad Nawaf. "Risk factors associated with oral candidiasis in elderly diabetic and non-diabetic patients wearing removable acrylic prostheses". Thesis, Queen's University Belfast, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.394634.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Ferreira, Elisangela Noborikawa. "Estudo comparativo de dois meios cromogênicos para identificação de espécies do gênero Candida, isoladas da mucosa oral de pacientes portadores de próteses totais completas ou uni maxilares superiores, com ou sem suspeita de candidíase oral". Universidade de São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/23/23139/tde-06032012-170254/.

Texto completo
Resumen
O gênero Candida abriga várias espécies de importância médica e embora algumas venham adquirindo interesse crescente, Candida albicans continua sendo a mais importante e responsável pelo maior número de infecções. Encontrada na microbiota de seres humanos saudáveis, é responsável pela infecção oral fúngica mais comum, em relação bastante estreita com a estomatite sob prótese (EP). Esta é um processo inflamatório da mucosa oral, comum em portadores de próteses dentárias, parciais ou totais subjacentes a uma prótese, onde também podem estar outros microrganismos, interagindo com diversos fatores, ligados ao hospedeiro e aos próprios microrganismos presentes no biofilme da superfície interna da prótese. A maioria dos casos é assintomática e alguns pacientes relatam dor, prurido ou sensação de ardência. O diagnóstico é clínico, complementado por exames tais como o citológico e o micológico direto. O tratamento é quase sempre empírico, sem a clara certeza se o indivíduo é portador da levedura e se outras espécies, estão envolvidas. Os meios cromogênicos possibilitaram avanço no diagnóstico das candidíases orais. Sua utilização facilita a identificação destas leveduras, com resultados em menor tempo que os dos métodos já padronizados para outras espécies de Candida. O CHROMagar Candida (CC) é a referência, fornecendo resultados em 48 horas após semeadura direta do material coletado. O meio denominado Candida Chromogenic Agar (CCA), foi recentemente lançado em nosso mercado e tendo em vista o seu baixo custo parece ser mais uma ferramenta para o diagnóstico da candidíase, embora não haja, ainda, literatura disponível sobre o seu emprego. O objetivo do presente trabalho, foi comparar esse novo meio ao CHROMagar Candida, quanto à sensibilidade e especificidade no isolamento de espécies do gênero Candida da mucosa oral de portadores de próteses totais superiores, com ou sem sintomas de EP. Participaram do estudo, 61 pacientes, de ambos os gêneros, portadores de próteses totais (45,9%) ou uni maxilares superiores (54,1%). Dentre as 61 amostras coletadas, 45 (73,77%) foram positivas para leveduras em CC, sendo C. Albicans (38 amostras, 24 únicas e e 14 (36,84%) mistas. Destas, 8 de C. Albicans + C. Tropicalis (21,05%); 3 de C. Albicans + C. glabrata (7,89%); 3 de C. albicans + C. tropicalis + C. glabrata (7,89%). Outras espécies presentes foram, 15 C. tropicalis (33,33%). Duas únicas (13,33%), duas mistas, C. tropicalis + C. glabrata (13,33%) e uma C. tropicalis + C. parapsilosis (6,66%). Em CCA, das 45 amostras, 39 foram positivas (86,6%). C. albicans, foi a mais frequente, com 33 isolados (84,6%), sendo, 25 únicas (75,75%) e 8 mistas (24,25%). Assim, C. albicans + C. tropicalis (5 12,82%); C. albicans + C. glabrata (2 5,13%); C. albicans + C. tropicalis + C. glabrata (uma 2,56%). Outras espécies isoladas foram: C. tropicalis (3 7,7%), e C. glabrata, C. krusei e C. parapsilosis (uma de cada 2,56%). Foi possível concluir que o CHROMagar Candida foi mais sensível (100% x 65%) e mais específico para albicans (84,4% x 73,3%); tropicalis (33,3% x 20,0%) e glabrata (17,7 % x 8,8%). Ambos apresentaram a mesma especificidade (2,2%), para krusei e parapsilosis.
The genus Candida includes several species of medical importance and although some will acquire increasing interest, Candida albicans remains the most important and responsible for more infections. Found in the microbiota of healthy humans, is responsible for the most common oral fungal infection in very close relation with denture stomatitis (EP). This is a frequent inflammation of the oral mucosa in complete or partial dentures wearers, where may also be present other microorganisms, interacting with several factors linked to the host and the microorganisms present themselves, in the inner surface of the biofilm of the prostheses. Most cases are asymptomatic and some patients report pain, itching or burning sensation. The diagnosis is clinical, supplemented by tests such as cytological and mycological. Treatment is often empiric, with no clear certainty whether the individual is only a carrier of yeast and if other species are involved. The chromogenic media enabled advances in the diagnosis of oral candidiasis. Its use facilitates the identification of these yeasts, resulting in less time than those of already standardized methods for other species of Candida. The CHROMagar Candida (CC) is the reference, providing results in 48 hours from the material collection. The medium called Chromogenic Candida Agar (CCA) was recently launched in our market and in view of its low cost seems to be one more tool for the diagnosis of candidiasis, although there is a lack of literature available on it. The objective of this study was to compare this new medium to CHROMagar Candida for sensitivity and specificity in the isolation of species of genus Candida from the oral mucosa of patients with upper dentures with or without symptoms of EP. Sixty one patients of both genders were recruited wearing complete dentures (45.9%) or uni upper jaw (54.1%) prostheses. Among the 61 samples, 45 (73.77%) were positive for yeasts in CC, and C. albicans (38 samples, 24 unique and 14 (36.84%) mixed. From these, 8 of C. albicans + C. tropicalis (21.05%), 3 of C. albicans + C. glabrata (7.89%), 3 of C. tropicalis + C. albicans + C. glabrata (7.89%). Other species were present, being 15 C. tropicalis (33.33%). Two unique isolates (13.33%), two mixed: C. tropicalis + C. glabrata (13.33%) and C. tropicalis + C. parapsilosis (6.66%). In CCA, from the 45 samples, 39 were positive (86.6%). C. albicans was the most frequent, with 33 isolates (84.6%), being unique in 25 (75.75%) and eight in mixed cultures (24.25%). Thus, C. albicans + C. tropicalis (5 - 12.82%); C. albicans + C. glabrata (2 - 5.13%), C. tropicalis + C. albicans + C. glabrata (1- 2.56%). Other species isolated were C. tropicalis (3 7.7%) and C. glabrata, C. krusei and C. parapsilosis (one of each - 2.56%). It was possible to conclude that CHROMagar Candida was more sensitive (100% vs. 65%) and more specific for C. albicans (84.4% vs. 73.3%), C. tropicalis (33.3% vs. 20.0%) and C. glabrata (17.7% vs. 8.8%). Both media showed the same specificity (2.2%), for C. krusei and C. parapsilosis.
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Oral Candidiasis"

1

R, Tyldesley William, ed. Oral candidosis. Middlesex [Eng]: E.R. Squibb, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Rosa, Edvaldo Antonio Ribeiro. Oral Candidosis: Physiopathology, Decision Making, and Therapeutics. Springer, 2015.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Rosa, Edvaldo Antonio Ribeiro. Oral Candidosis: Physiopathology, Decision Making, and Therapeutics. Springer, 2016.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Levine, Steven. Herbs for Oral Thrush: Complete Guide on How to Treat Oral Candidiasis Using Natural Remedies. Independently Published, 2021.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Gerd, Mindel. Miconazole: Cure for Vaginal Candidiasis, Jock Itch, Skin Infection, Oral Thrush. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

P, Samaranayake Lakshman y MacFarlane T. Wallace, eds. Oral candidosis: Edited by Lakshman P. Samaranayake, T. Wallace MacFarlane ; with a foreword by Jen J. Pindborg. London: Wright, 1990.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Rose, Canida. Metronidazole: Cure for Most Bacterial and Fungi Infection Like Bacterial Vaginosis, Oral Candidiasis and Thrush. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Crack, Jader. Ketoconazole: Ultimate Treatment for Fungal Infection Like Oral Thrush, Candidiasis, Toe Nail Infection, Jock Itch. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Jack, Jery. Metronidazole: Treatment of Bacteria and Fungi Infection Like Vaginosis, Candidiasis, Oral Thrush and Skin Rash. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Koto, Cori. Metronidazole: Medication for the Treatment of Parasitic, Bacteria, Fungi Infection Like Bacterial Vaginosis, Candidiasis, Oral Thrush. Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Oral Candidiasis"

1

De Rossi, Scott S. y Katharine Ciarrocca. "Oral Candidiasis". En Orofacial Disorders, 53–60. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-51508-3_6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Gelwan, Jeffrey S., Burton M. Gold, Henry J. Shih y Crescens Pellecchia. "Oral candidiasis and AIDS". En Acquired Immunodeficiency Syndrome, 123–24. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-0807-2_35.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Rezaei, Nima. "Oral Ulcers and Candidiasis". En Pediatric Immunology, 259–63. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21262-9_51.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Kragelund, Camilla, Jesper Reibel y Anne Marie Lynge Pedersen. "Management of Patients with Oral Candidiasis". En Oral Infections and General Health, 137–44. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-25091-5_13.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Dongari-Bagtzoglou, Anna. "Innate Defense Mechanisms in Oral Candidiasis". En Fungal Immunology, 13–35. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Öner, Ümran, Fatih Öner, Cemal Cingi y Torello M. Lotti. "Oral Candidiasis in Infants and Children". En Pediatric ENT Infections, 489–501. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-80691-0_42.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Kragelund, Camilla, Jesper Reibel y Anne Marie Lynge Pedersen. "Oral Candidiasis and the Medically Compromised Patient". En Oral Infections and General Health, 65–77. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-25091-5_8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Junqueira, Juliana Campos. "Models Hosts for the Study of Oral Candidiasis". En Advances in Experimental Medicine and Biology, 95–105. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-5638-5_10.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Ashman, Robert B. y Camile S. Farah. "Oral Candidiasis: Clinical Manifestations and Cellular Adaptive Host Responses". En Fungal Immunology, 59–83. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Challacombe, Stephen J., Durdana Rahman, Mukesh Mistry y Julian R. Naglik. "Humoral Factors in the Protection of the Oral Cavity against Candidiasis". En Fungal Immunology, 37–57. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/0-387-25445-5_3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Oral Candidiasis"

1

SEVBITOV, Andrey, Aleksey DOROFEEV, Sergey MIRONOV, Samer AL-KHOURY y Anton TIMOSHIN. "PREVENTION OF CANDIDIASIS IN PATIENTS USING REMOVABLE DENTURES". En SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE. DR. D. SCIENTIFIC CONSULTING, 2022. http://dx.doi.org/10.48141/sbjchem.21scon.04_abstract_sevbitov.pdf.

Texto completo
Resumen
Despite innovations in orthopedic dentistry, removable dentures belong to the most popular orthopedic care category. Removable dentures are combined stimuli that affect the mucous membrane and neuro-receptor apparatus. Acrylic plastic prostheses, widely used in prosthetic dentistry, have a negative side mechanical, chemical-toxic, sensitizing, and thermal insulating effect on oral tissue and prosthetic impression area. This is often complicated by a violation of the biocenosis of the oral cavity, the growth of pathogenic microflora that releases toxins, especially an increase in the number of yeast colonies that irritate the oral mucosa and prosthetic stomatitis. It was observed 100 patients with oral candidiasis of various age groups from 45 to 65 years. Of these, 60 patients with removable plate prostheses; 40 patients with partially removable prostheses. Chronic forms of candidiasis were diagnosed in 40 patients and with exacerbation of chronic forms of candidiasis in 60 people. The number of untreated carious cavities and poor hygienic condition of the oral cavity directly affects the severity of candidiasis. Acute forms of candidiasis were observed mainly in patients with high DMF and PMA indices. The severity of candidiasis depends on the degree and duration of wearing dentures and hygienic conditions - the most severe forms of invasive candidiasis were observed in the presence of removable plate prostheses, the complete absence of teeth, and the use of a prosthesis for more than 10-15 years. A combined lesion of the oral mucosa and the red border of the lips was observed mainly in patients older than 60 years. The presence of candidiasis in the oral cavity in patients with removable plate prostheses leads to a statistically significant change in the indicators of local immunity of the oral cavity: an increase in the concentration of serum IgG and IgA and the values of the coefficient of the balance of local immunity factors.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Femilian, Afryla. "Salivary Calprotectin in Patient With Oral Candidiasis". En 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/ahsr.k.210115.060.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Baggott, R., S. Glavey, M. Power y A. O'Regan. "Prevalence of Oral Candidiasis at Bronchoscopy and Response to Treatment." En American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2591.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Khan, Sanober, B. H. Harshitha Gowda, R. Deveswaran, Sweekriti Mishra y Anoop Sharma. "Comparison of fluconazole and tea tree oil hydrogels designed for oral candidiasis: An invitro study". En PROCEEDINGS OF INTERNATIONAL CONFERENCE ON ADVANCES IN MATERIALS RESEARCH (ICAMR - 2019). AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0022601.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Pierce, Christine M., Stephanie Hogue, Shirlene Paul, Bo-Young Hong, Wildson Vieira da Silva, Maria F. Gomez, Anna R. Giuliano, Jimmy J. Caudell y George M. Weinstock. "Abstract 3326: Mucositis, candidiasis, and associations with the oral microbiome in treatment naive patients with oropharyngeal cancer". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-3326.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Pierce, Christine M., Stephanie Hogue, Shirlene Paul, Bo-Young Hong, Wildson Vieira da Silva, Maria F. Gomez, Anna R. Giuliano, Jimmy J. Caudell y George M. Weinstock. "Abstract 3326: Mucositis, candidiasis, and associations with the oral microbiome in treatment naive patients with oropharyngeal cancer". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-3326.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Tozzo, Ana Claudia, Iasmine Guardia Dos Santos, Fabiane Froes Mattiuzi y Alcione De Oliveira Dos Santos. "FATORES ASSOCIADOS A CANDIDÍASE VAGINAL RECORRENTE". En I Congresso Brasileiro de Doenças Infectocontagiosas On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/2173.

Texto completo
Resumen
Introdução: A candidíase vaginal recorrente é uma infecção que ocorre de forma frequente na vida da mulher. O trato genital feminino é acometido por fungos, sendo o principal a Candida albicans, que gera um desequilíbrio da flora vaginal por alterações fisiológicas ou não. Objetivos: Estudar os fatores que influenciam no surgimento da candidíase e quais os meios de prevenção devem ser reforçados para que a mesma não venha a surgir. Material e métodos: Foram utilizados como materiais e método para atingir os propósitos da presente pesquisa o estudo de revisão bibliográfica relacionado a candidíase, através da análise de artigos científicos encontrados na plataforma Scielo datados de 2010 a 2020 tanto em língua portuguesa quanto em inglesa publicados em revistas médicas. As palavras chaves utilizadas para a pesquisa foram "candídiase recorrente", "candidíase vaginal" e "recurrent candidiasis". Foram selecionados os artigos mais relevantes à proposta do artigo e que melhor se adequaram a atingir os objetivos descritos para a pesquisa. Resultados: Foi observado que a candidíase vaginal é recorrente quando ocorre no mínimo quatro casos de infecção ao ano. Os fatores que a desencadeiam ocorrem predominantemente àquelas mulheres que tem hábitos considerados de risco, como o uso de roupas com tecido sintéticos, justas na região perineal, bem como as portadora de diabetes, disfunções hormonais e as que sofrem estresse diariamente. Ainda, constatou-se o fato de que a mudança alimentar para uma nutrição saudável contribue para a cura e prevenção da candidíase. Conclusão: Os estudos mostram que o fungo que mais causa candidíase é o Candida albicans, ainda que existam outros. O tratamento indicado tradicionalmente é o uso de pomada vaginal e medicamento oral, além disso, algumas mudanças de hábitos alimentares podem ser preventivas. Uma das formas de diminuir os fatores seria evita-los e agregar uma alimentação saudável na vida cotidiana da mulher, aliado a distribuição de informações acerca do assunto quanto a profilaxia dessa infeccção que hostiliza tão frequentemente as mulheres.
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Oral Candidiasis"

1

Hu, Qiaoyu y Na Liu. A meta-analysis of the efficacy of photodynamic therapy for oral candidiasis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, diciembre de 2022. http://dx.doi.org/10.37766/inplasy2022.12.0053.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Oral Candidiasis" para tipos de fuentes particulares:
Artículos de revistas Tesis Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía